Cart
0

Wearable Injectors Market by Type (On-body {Adhesive Patch}, Off-body {Belt Clip}, and Hand-held), Usage (Disposable and Semi-reusable), Technology (Electronic Injectors, Mechanical Injectors, and Others), Mechanism of Injection (Motor-driven, Spring-based, Expanding Battery, Rotary Pump, Collapsible Reservoir, and Pressurized Gas), Therapeutic Area (Diabetes, Oncology, Cardiovascular Diseases, Infectious Diseases, and Auto-immune Disorders), and End User (Clinics, Hospitals, Ambulatory Surgery Centers, Home Care Settings, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_183755
Pages: NA
Jan 2019 | 760 Views
 
Author's : NA
Tables: NA
Charts: NA
 

Wearable injectors are drug delivery devices based on single-use wearable device technologies, designed to deliver drugs in large volume to the patients treated for long duration. Rapid ongoing developments with many new designed features of these have been witnessed in the medical field. Wearable injectors offer numerous benefits to the patients due to their wide usage.

The global wearable injectors market is driven by the advantages as compared to traditional injectors, ease of customization, and increase in demand for home healthcare and advanced drug delivery system. Growth in need for subcutaneous and continuous drug delivery has created the demand for wearable injectors among the patients. However, low dosing volume of administering drugs and highly viscous nature of few drugs impede the market growth. Moreover, rise in need for better patient care and growth in focus of pharmaceutical companies to penetrate in the market offer ample opportunities for market development.

The global wearable injectors market is segmented based on type, usage, technology, mechanism of injection, therapeutic area, end user, and region. On the basis of type, it is divided into on-body {adhesive patch}, off-body {belt clip}, and hand-held. Based on usage, it is bifurcated into disposable and semi-reusable. Based on technology, it is classified into electronic injectors, mechanical injectors, and others. On the basis of mechanism of injection, it is categorized into motor-driven, spring-based, expanding battery, rotary pump, collapsible reservoir, and pressurized gas. On the basis of therapeutic area, it is divided into diabetes, oncology, cardiovascular diseases, infectious diseases, and auto-immune disorders. Based on end user, it is divided into clinics, hospitals, ambulatory surgery centers, home care settings, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in this market are Enable Injections, SteadyMed Therapeutics, Inc., Insulet Corporation, UNILIFE CORPORATION, Sensile Medical AG, West Pharmaceutical Services, Inc., Becton, Dickinson and Company, Bhler Motor GmbH, Ypsomed, and Amgen Inc.,

Key Benefits

  • The study provides an in-depth analysis of the global wearable injectors market along with current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market by product assists to understand the various forms of wearable injectors available.
  • Key players are profiled and their strategies are analyzed thoroughly to predict the competitive outlook of the market.

Wearable Injectors Market Key Segments:

By Type

  • On-body (adhesive patch)
  • Off-body (belt clip)
  • Hand-held

By Usage

  • Disposable

  • Semi-reusable

By Technology

  • Electronic Injectors
  • Mechanical Injectors
  • Others

By Mechanism of Injection

  • Motor-driven
  • Spring-based
  • Expanding Battery
  • Rotary Pump
  • Collapsible Reservoir
  • Pressurized Gas

By Therapeutic Area

  • Diabetes
  • Oncology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Auto-immune Disorders

By End User

  • Clinics
  • Hospitals
  • Ambulatory Surgery Centers
  • Home Care Settings
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 WEARABLE INJECTORS MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. ON-BODY (ADHESIVE PATCH)

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. OFF-BODY (BELT CLIP)

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. HAND-HELD

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

Chapter: 5 WEARABLE INJECTORS MARKET, BY USAGE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. DISPOSABLE

5.2.1. Market size and forecast

5.3. SEMI-REUSABLE

5.3.1. Market size and forecast

Chapter: 6 WEARABLE INJECTORS MARKET, BY TECHNOLOGY

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. ELECTRONIC INJECTORS

6.2.1. Market size and forecast

6.3. MECHANICAL INJECTORS

6.3.1. Market size and forecast

6.4. OTHERS

6.4.1. Market size and forecast

Chapter: 7 WEARABLE INJECTORS MARKET, BY MECHANISM OF INJECTION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. MOTOR-DRIVEN

7.2.1. Market size and forecast

7.3. SPRING-BASED

7.3.1. Market size and forecast

7.4. EXPANDING BATTERY

7.4.1. Market size and forecast

7.5. ROTARY PUMP

7.5.1. Market size and forecast

7.6. COLLAPSIBLE RESERVOIR
7.7. PRESSURIZED GAS

7.7.1. Market size and forecast

Chapter: 8 WEARABLE INJECTORS MARKET, BY THERAPEUTIC AREA

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. DIABETES

8.2.1. Market size and forecast

8.3. ONCOLOGY

8.3.1. Market size and forecast

8.4. CARDIOVASCULAR DISEASES

8.4.1. Market size and forecast

8.5. INFECTIOUS DISEASES

8.5.1. Market size and forecast

8.6. AUTO-IMMUNE DISORDERS

8.6.1. Market size and forecast

Chapter: 9 WEARABLE INJECTORS MARKET, BY END USER

9.1. OVERVIEW

9.1.1. Market size and forecast

9.2. CLINICS

9.2.1. Market size and forecast

9.3. HOSPITALS

9.3.1. Market size and forecast

9.4. AMBULATORY SURGERY CENTERS

9.4.1. Market size and forecast

9.5. HOME CARE SETTINGS

9.5.1. Market size and forecast

9.6. OTHERS

9.6.1. Market size and forecast

Chapter: 10 WEARABLE INJECTORS MARKET, BY GEOGRAPHY

10.1. OVERVIEW
10.2. NORTH AMERICA

10.2.1. Key market trends
10.2.2. Key growth factors and opportunities
10.2.3. Market size and forecast

10.2.3.1. U.S. market size and forecast
10.2.3.2. Canada market size and forecast
10.2.3.3. Mexico market size and forecast

10.2.4. North America Wearable Injectors Market by Type
10.2.5. North America Wearable Injectors Market by Usage
10.2.6. North America Wearable Injectors Market by Technology
10.2.7. North America Wearable Injectors Market by Mechanism of Injection
10.2.8. North America Wearable Injectors Market by Therapeutic Area
10.2.9. North America Wearable Injectors Market by End User

10.3. EUROPE

10.3.1. Key market trends
10.3.2. Key growth factors and opportunities
10.3.3. Market size and forecast

10.3.3.1. Germany market size and forecast
10.3.3.2. France market size and forecast
10.3.3.3. UK market size and forecast
10.3.3.4. Spain market size and forecast
10.3.3.5. Rest of Europe market size and forecast

10.3.4. Europe Wearable Injectors Market by Type
10.3.5. Europe Wearable Injectors Market by Usage
10.3.6. Europe Wearable Injectors Market by Technology
10.3.7. Europe Wearable Injectors Market by Mechanism of Injection
10.3.8. Europe Wearable Injectors Market by Therapeutic Area
10.3.9. Europe Wearable Injectors Market by End User

10.4. ASIA-PACIFIC

10.4.1. Key market trends
10.4.2. Key growth factors and opportunities
10.4.3. Market size and forecast

10.4.3.1. Japan market size and forecast
10.4.3.2. China market size and forecast
10.4.3.3. Australia market size and forecast
10.4.3.4. India market size and forecast
10.4.3.5. Rest of Asia-Pacific market size and forecast

10.4.4. Asia-Pacific Wearable Injectors Market by Type
10.4.5. Asia-Pacific Wearable Injectors Market by Usage
10.4.6. Asia-Pacific Wearable Injectors Market by Technology
10.4.7. Asia-Pacific Wearable Injectors Market by Mechanism of Injection
10.4.8. Asia-Pacific Wearable Injectors Market by Therapeutic Area
10.4.9. Asia-Pacific Wearable Injectors Market by End User

10.5. LAMEA

10.5.1. Key market trends
10.5.2. Key growth factors and opportunities
10.5.3. Market size and forecast

10.5.3.1. Brazil market size and forecast
10.5.3.2. Turkey market size and forecast
10.5.3.3. Saudi Arabia market size and forecast
10.5.3.4. South Africa market size and forecast
10.5.3.5. Rest of LAMEA market size and forecast

10.5.4. LAMEA Wearable Injectors Market by Type
10.5.5. LAMEA Wearable Injectors Market by Usage
10.5.6. LAMEA Wearable Injectors Market by Technology
10.5.7. LAMEA Wearable Injectors Market by Mechanism of Injection
10.5.8. LAMEA Wearable Injectors Market by Therapeutic Area
10.5.9. LAMEA Wearable Injectors Market by End User

Chapter: 11 COMPANY PROFILES

11.1. ENABLE INJECTIONS

11.1.1. Operating business segments
11.1.2. Business performance
11.1.3. Key strategic moves and developments

11.2. STEADYMED THERAPEUTICS INC.

11.2.1. Operating business segments
11.2.2. Business performance
11.2.3. Key strategic moves and developments

11.3. INSULET CORPORATION

11.3.1. Operating business segments
11.3.2. Business performance
11.3.3. Key strategic moves and developments

11.4. UNILIFE CORPORATION

11.4.1. Operating business segments
11.4.2. Business performance
11.4.3. Key strategic moves and developments

11.5. SENSILE MEDICAL AG

11.5.1. Operating business segments
11.5.2. Business performance
11.5.3. Key strategic moves and developments

11.6. WEST PHARMACEUTICAL SERVICES, INC.

11.6.1. Operating business segments
11.6.2. Business performance
11.6.3. Key strategic moves and developments

11.7. BECTON, DICKINSON AND COMPANY

11.7.1. Operating business segments
11.7.2. Business performance
11.7.3. Key strategic moves and developments

11.8. BÜHLER MOTOR GMBH

11.8.1. Operating business segments
11.8.2. Business performance
11.8.3. Key strategic moves and developments

11.9. YPSOMED

11.9.1. Operating business segments
11.9.2. Business performance
11.9.3. Key strategic moves and developments

11.10. AMGEN INC.

11.10.1 Operating business segments
11.10.2 Business performance
11.10.3 Key strategic moves and developments

 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request TOC/Sample

Request Customization

Request TOC/Sample

OR

Purchase Full Report of
Wearable Injectors Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $3456 $3111
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840 $3456
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370 $4833
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450 $5805
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995 $8096
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo